Rockefeller Capital Management
STIM icon

Rockefeller Capital Management’s Neuronetics STIM Stock Holding History

Rockefeller Capital Management’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-1,500
Closed -$1.95K – 4976
2026
Q2 		$1.95K Hold
1,500
– – ﹤0.01% 4435
2026
Q1 		$2.18K Hold
1,500
– – ﹤0.01% 4401
2025
Q4 		$2.07K Hold
1,500
– – ﹤0.01% 4308
2025
Q3 		$4.1K Buy
+1,500
New +$5.33K ﹤0.01% 3932

Other funds holding STIM

Madryn Asset Management
Madryn Asset Management New York $55.5M AUM 7.4% 1-Year Est. Return
Wexford Capital
Wexford Capital West Palm Beach, Florida $763M AUM 59.25% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $114B AUM 35.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Lane Generational
Lane Generational Dover, Massachusetts $111M AUM 16.63% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $106B AUM 21.33% 1-Year Est. Return
AdvisorShares Investments
AdvisorShares Investments Bethesda, Maryland $796M AUM 17.24% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Rockefeller Capital Management's STIM Position: Q3 2026 in Review

Rockefeller Capital Management sold out of Neuronetics (STIM) in Q3 2026, closing a stake of 1,500 shares — an estimated $1.95K sold.

Rockefeller Capital Management first reported a position in STIM in Q3 2025 and held it in 4 quarters. The position peaked at $4.1K in Q3 2025. 58 funds tracked by Wall St. Rank hold STIM as of Q3 2026.

  • Rockefeller Capital Management reported no remaining Neuronetics position as of Q3 2026 after selling out during the quarter.
  • Rockefeller Capital Management sold 1,500 Neuronetics shares in Q3 2026, an estimated $1.95K.
  • Rockefeller Capital Management first reported a position in Neuronetics in Q3 2025 and held it in 4 quarters.
  • Rockefeller Capital Management's Neuronetics position peaked at $4.1K in Q3 2025.
  • 58 funds tracked by Wall St. Rank held Neuronetics as of Q3 2026.

Based on Rockefeller Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.